--Hyster-Yale Keeps Quarterly Dividend at $0.35 Per Share; Payable Dec. 13 to Shareholders of Record Nov. 29-February 2024-www.financetom.com

--Hyster-Yale Keeps Quarterly Dividend at $0.35 Per Share; Payable Dec. 13 to Shareholders of Record Nov. 29

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Hyster-Yale Keeps Quarterly Dividend at $0.35 Per Share; Payable Dec. 13 to Shareholders of Record Nov. 29

Nov 13, 2024 12:11 PM

02:40 PM EST, 11/13/2024 (MT Newswires) --

Price: 53.14, Change: +0.35, Percent Change: +0.67

Previous page： --Lennar Q2 New Orders Rise 19% to 21,293 Homes vs Visible Alpha Analyst Consensus of 21,118 Next page： Sentinelone Insider Sold Shares Worth $1,110,658, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Lennar Q2 New Orders Rise 19% to 21,293 Homes vs Visible Alpha Analyst Consensus of 21,118

Jun 17, 2024

04:32 PM EDT, 06/17/2024 (MT Newswires) -- Price: 157.83, Change: +1.32, Percent Change: +0.84 ...

Sentinelone Insider Sold Shares Worth $1,110,658, According to a Recent SEC Filing

Jun 17, 2024

04:36 PM EDT, 06/17/2024 (MT Newswires) -- Tomer Weingarten, Director, President, CEO, on June 13, 2024, sold 60,864 shares in Sentinelone ( S ) for $1,110,658. Following the Form 4 filing with the SEC, Weingarten has control over a total of 1,119,312 shares of the company, with 1,119,312 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1583708/000186622224000027/xslF345X03/wk-form4_1718656276.xml ...

Vaxart Stock Is Moving Higher After The Bell: What's Going On?

Jun 17, 2024

Vaxart Inc ( VXRT ) shares are trading higher in Monday’s after-hours session after the company provided business and cash runway updates. What Happened: Vaxart ( VXRT ), a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project NextGen award are expected to extend the company’s...

United Therapeutics Insider Sold Shares Worth $1,033,984, According to a Recent SEC Filing

Jun 17, 2024

04:36 PM EDT, 06/17/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on June 14, 2024, sold 3,600 shares in United Therapeutics ( UTHR ) for $1,033,984. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 647,195 shares of the company, with 130 shares held directly and 647,065 controlled indirectly. SEC Filing:...